Select Page
Skip to main content
< All Topics
Print

Ipamorelin

🔍 Description:

Ipamorelin is a potent growth hormone-releasing peptide (GHRP) that acts as a selective ghrelin receptor agonist. It stimulates the release of growth hormone (GH) by mimicking the action of ghrelin, the body’s natural hunger hormone. What sets Ipamorelin apart from other GHRPs is its ability to increase GH levels without significantly raising cortisol or prolactin levels, minimizing the activation of the body’s stress response and making it a preferred choice for those seeking the benefits of growth hormone therapy with minimal side effects.

💪 Health Benefits:

Muscle Growth: Ipamorelin effectively promotes lean muscle mass and strength gains by stimulating the body’s natural production of GH. It enhances protein synthesis and muscle recovery, making it a valuable tool for athletes and those undergoing physical rehabilitation&#8203;:contentReference[oaicite:2]{index=2}. Notably, it has been observed to counteract glucocorticoid-induced muscle catabolism, which further supports muscle growth.

Fat Loss: By increasing GH levels, Ipamorelin boosts fat metabolism, leading to more efficient use of body fat as an energy source and aiding in overall fat reduction. This is particularly beneficial when combined with a healthy diet and regular exercise.

Sleep Quality: One of the standout benefits of Ipamorelin is its positive impact on sleep. It promotes deeper, more restorative sleep, which is crucial for recovery, cognitive function, and overall well-being. Improved sleep quality also supports better hormonal balance and energy levels.

Anti-Aging and Bone Health: Ipamorelin has shown promise in promoting bone density and potentially supporting cartilage and skin health by increasing collagen synthesis. This makes it beneficial for anti-aging and injury recovery.

💉 Dosing/Administration:

Typical Dosage: The recommended dosage for Ipamorelin ranges from 200-300 mcg per day. For research purposes, the dosage can be tailored based on specific goals such as muscle growth or anti-aging.

Administration Method: Ipamorelin is typically administered via subcutaneous injection. To align with the body’s natural GH rhythms, it is usually injected before bedtime, maximizing GH release during sleep. For certain applications, daily doses of 200 mcg or more may be split into 2-3 injections per day to sustain GH levels throughout the day.

Cycling: To prevent the body from adapting to Ipamorelin and to maintain its effectiveness, it is commonly cycled. A typical cycle might involve using Ipamorelin for 8-12 weeks, followed by a 4-week break.

⚠️ Side Effects and Safety:

Common Side Effects: Ipamorelin is well-known for its mild side effect profile. Common side effects are generally minimal and may include mild water retention, slight headaches, or localized irritation at the injection site. Unlike other GHRPs, Ipamorelin does not cause significant spikes in cortisol or prolactin, reducing the risk of associated side effects like anxiety or water retention&#8203;:contentReference[oaicite:11]{index=11}. However, because Ipamorelin mimics ghrelin, it may increase appetite in some users.

Safety Profile: Ipamorelin is considered one of the safest peptides for increasing GH levels, largely due to its selective action on GH release. It does not induce significant hunger or raise stress hormones, making it a favored option for long-term use. However, regular monitoring of GH and IGF-1 levels is advised to ensure optimal dosing and to avoid potential long-term effects. While generally well-tolerated, it is important to handle Ipamorelin with caution, particularly in research settings.

References:

1. Ipamorelin | Reviews, Clinical Trials, and Safety. [Link to Source](https://www.peptides.org/ipamorelin/).

2. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. doi:10.1530/eje.0.1390552.

3. Andersen NB, Malmlöf K, Johansen PB, Andreassen TT, Ørtoft G, Oxlund H. The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth Horm IGF Res. 2001;11(5):266-272. doi:10.1054/ghir.2001.0239.

4. Svensson J, Lall S, Dickson SL, et al. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. J Endocrinol. 2000;165(3):569-577. doi:10.1677/joe.0.1650569.

5. Laferrère B, Abraham C, Russell CD, Bowers CY. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab. 2005;90(2):611-614. doi:10.1210/jc.2004-1719.